Research programme: targeted DNA therapeutics - Gennao Bio
Alternative Names: Targeted DNA therapeutics - Gennao Bio; Targeted nucleic acid therapeutics - Gennao BioLatest Information Update: 08 Apr 2024
At a glance
- Originator Gennao Bio
- Class Antineoplastics; DNA; Drug conjugates; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer; Musculoskeletal disorders